Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-005918
Filing Date
2014-11-19
Accepted
2014-11-19 15:19:16
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1752916
2 CERTIFICATION cbmg_ex311.htm EX-31.1 15934
3 CERTIFICATION cbmg_ex312.htm EX-31.2 16021
4 CERTIFICATION cbmg_ex321.htm EX-32.1 8421
  Complete submission text file 0001354488-14-005918.txt   5957265

Data Files

Seq Description Document Type Size
5 cmbg-20140930.xml EX-101.INS 667044
6 cmbg-20140930.xsd EX-101.SCH 46235
7 cmbg-20140930_cal.xml EX-101.CAL 66079
8 cmbg-20140930_def.xml EX-101.DEF 89259
9 cmbg-20140930_lab.xml EX-101.LAB 323581
10 cmbg-20140930_pre.xml EX-101.PRE 228193
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 141234866
SIC: 6199 Finance Services